Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Hypothetico‐Deductive Reasoning in Direct Oral Anticoagulant Trial Meta‐Analyses: A Meta‐Epidemiological Study
Quentin Remy; Arthur Gougeon; Paul Riallin; Rémy Boussageon; Jean‐Christophe LegaShow moreShow less
1. Département de médecine générale Université Claude Bernard Lyon 1 Lyon France; 2. Laboratoire de Biométrie et Biologie Evolutive UMR 5558, CNRS Université Lyon 1, Université de Lyon Villeurbanne France; 3. Service de Rhumatologie, Hôpital Lyon Sud Hospices Civils de Lyon Lyon France; 4. Service Hospitalo‐Universitaire de Pharmacotoxicologie, Pôle Santé Publique Hospices Civils de Lyon Lyon FranceShow moreShow less
Human Airway Epithelial Cell Line Responses to Cigarette Smoke Extract and LPS: Insights Into Mucus and Cytokine Regulation
Aude Bodin; Tatiana Victoni; Yann Verres; Pascale Bellaud; Anne Casset; Alain Fautrel; Thomas Gicquel; Françoise Pons; Vincent LagenteShow moreShow less
1. NuMeCan Institute (Nutrition, Metabolism and Cancer) Univ Rennes, INSERM, INRAE, CHU Rennes Rennes France; 2. University of Lyon, VetAgro Sup Laboratory APCSe Marcy l'Étoile France; 3. H2P2 (Histopathology High precision) Platform, Univ Rennes Rennes France; 4. Université de Strasbourg, CNRS CAMB UMR 7199 Strasbourg FranceShow moreShow less
Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin‐Tazobactam for the Population With Obesity: An Open Randomized Controlled Feasibility Study (TAZO‐OBESITY Trial)
Sabrina Larocque; Juliette Fournier; Justine Brasseur‐Masse; Britanny Bernard; Guiva Annane; Louis‐Patrick Haraoui; Anis Ouyahia; Amélie Marsot; Benoît CrevierShow moreShow less
1. Faculty of Pharmacy Université de Montréal Montréal Québec Canada; 2. STP2 Laboratory, Faculty of Pharmacy Université de Montréal Montréal Québec Canada; 3. Department of Microbiology and Infectious Diseases Université de Sherbrooke Sherbrooke Québec Canada; 4. Charles‐Le Moyne Research Center Centre intégré de santé et de services sociaux de la Montérégie‐Centre Greenfield Park Québec Canada; 5. Humans and the Microbiome Program Canadian Institute for Advanced Research Toronto Ontario Canada; 6. Department of Pharmacy Centre intégré de santé et de services sociaux de la Montérégie‐Centre Greenfield Park Québec Canada; 7. Research Center CHU Sainte‐Justine Montréal Québec CanadaShow moreShow less
Vitamin D Supplementation and Mortality in the Elderly: A Review of a Meta‐Analysis of Randomized Controlled Trials Using the REB Method
Natalia Kostakis; Jean‐Christophe Lega; Remy BoussageonShow moreShow less
1. Collège Universitaire de Médecine Générale Université Claude Bernard Lyon 1 Lyon France; 2. Équipe Évaluation et Modélisation des Effets Thérapeutiques, Laboratoire de Biométrie et Biologie Evolutive Université Claude Bernard Lyon 1 Lyon France; 3. Lyon Immunophathology Federation (LIFe) Hospices Civils de Lyon Lyon France; 4. Service Hospitalo‐Universitaire de Pharmacotoxicologie Hospices Civils de Lyon Lyon France; 5. Service de Rhumatologie, Hôpital Lyon Sud Hospices Civils de Lyon Pierre‐Bénite FranceShow moreShow less
Exploring the Molecular Mechanisms of SB216763 in the Therapeutic Intervention of Pulmonary Fibrosis Based on Macrophage Functional Plasticity
Yunuo Zhou; Pei Zhou; Jianhong QiShow moreShow less
1. School of Life Science and Technology China Pharmaceutical University Nanjing China; 2. School of Pharmacy China Pharmaceutical University Nanjing ChinaShow moreShow less
Redefining Regulatory Proof: The End of the Two‐Trial Paradigm
Jean‐Christophe Lega; Steeve Provencher; Bruno Falissard; Clara Locher; Matthieu Roustit; Arthur Gougeon; Rémy Boussageon; Sylvie ChevretShow moreShow less
1. Laboratoire de Biométrie et Biologie Evolutive, UMR CNRS 5558 Université Lyon 1, Université de Lyon Villeurbanne France; 2. Service Hospitalo‐Universitaire de Pharmacotoxicologie, Pôle Santé Publique Hospices Civils de Lyon Lyon France; 3. Institut Universitaire de Cardiologie et de Pneumologie de Québec, Pulmonary Hypertension Research Group Laval University Québec City Québec Canada; 4. CESP, INSERM U1018 Université Paris‐Saclay Villejuif France; 5. Irset (Institut de recherche en santé, environnement et travail), UMR 1085, CIC 1414 (Centre of Clinical Investigation of Rennes) University of Rennes, CHU Rennes, Inserm Rennes France; 6. U1300, CIC 1406 Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes Grenoble France; 7. ECSTRRA Team, UMR 1342 Université Paris Cité, Inserm Paris Cedex FranceShow moreShow less
FAQ
How long does FUNDAMENTAL & CLINICAL PHARMACOLOGY take to review a manuscript?
As of 2026-11-17, CrushSCI has 16 complete review records for FUNDAMENTAL & CLINICAL PHARMACOLOGY. The fastest paper went from submission to acceptance in 72 days (Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis‐ and Angiogenesis‐Related Proteins, received 2026-04-04, accepted 2026-06-15); the slowest took 403 days. The average is 180.7 days and the median is 137.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
